Search research articles
Contact Us
Filters
Showing results (31-40 of 334) with videos related to
Page
of 34
Sort By:
European Urology Focus
|
December 3, 2025
Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118-25
Ciro Piccolo, Alessandro Larcher, Francesco Cei, et al.
The Journal of Urology
|
September 7, 2014
Re: Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors: T. Klatte, S. F. Shariat and M. Remzi. J Urol 2014; 191: 1209-1217
Alessandro Larcher, Nicola Fossati, Massimo Lazzeri, et al.
European Urology
|
May 9, 2016
Reply from Authors re: Steven C. Campbell, Wen Dong, Joe Zabell, Diego Aguilar Palacios. End-stage Renal Disease After Renal Surgery: Partial Nephrectomy Is Protective, but to What Degree and Consequence? Eur Urol 2016;70:562-3: Functional Outcomes After Renal Surgery: It's Time to Change Our Point of View
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
European Urology
|
April 3, 2024
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63-71
Giuseppe Basile, Alessandro Larcher, Arturo Chiti, et al.
The Lancet. Oncology
|
July 3, 2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors
Alessandro Larcher, Umberto Capitanio, Andrea Necchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2022
Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting
Umberto Capitanio, Giuseppe Rosiello, Andrea Necchi, et al.
Minerva Urology and Nephrology
|
February 11, 2022
Are we ready for single overnight stay after robot-assisted partial nephrectomy?
Federico Piramide, Filippo Turri, Paolo Dell'oglio, et al.
The Journal of Urology
|
September 10, 2024
Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma
Mattia Longoni, Giuseppe Rosiello, Alessandro Larcher, et al.
European Urology Oncology
|
June 4, 2019
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery
Umberto Capitanio, Andrea Necchi, Alessandro Larcher, et al.
European Urology
|
December 23, 2015
Reply from Authors re: Matthew C. Hayes, David J. Breen. Excision Versus Ablation in Renal Cancer: Optimising Outcome and Minimising Risk. Eur Urol 2016;69:683-4
Alessandro Larcher, Nicola Fossati, Paolo Dell'Oglio, et al.
Page
of 34
Search research articles
Search
Showing results (31-40 of 334) with videos related to
Sort By:
Page
of 34
European Urology Focus
|
December 3, 2025
Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118-25
Ciro Piccolo, Alessandro Larcher, Francesco Cei, et al.
The Journal of Urology
|
September 7, 2014
Re: Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors: T. Klatte, S. F. Shariat and M. Remzi. J Urol 2014; 191: 1209-1217
Alessandro Larcher, Nicola Fossati, Massimo Lazzeri, et al.
European Urology
|
May 9, 2016
Reply from Authors re: Steven C. Campbell, Wen Dong, Joe Zabell, Diego Aguilar Palacios. End-stage Renal Disease After Renal Surgery: Partial Nephrectomy Is Protective, but to What Degree and Consequence? Eur Urol 2016;70:562-3: Functional Outcomes After Renal Surgery: It's Time to Change Our Point of View
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
European Urology
|
April 3, 2024
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63-71
Giuseppe Basile, Alessandro Larcher, Arturo Chiti, et al.
The Lancet. Oncology
|
July 3, 2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors
Alessandro Larcher, Umberto Capitanio, Andrea Necchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 27, 2022
Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting
Umberto Capitanio, Giuseppe Rosiello, Andrea Necchi, et al.
Minerva Urology and Nephrology
|
February 11, 2022
Are we ready for single overnight stay after robot-assisted partial nephrectomy?
Federico Piramide, Filippo Turri, Paolo Dell'oglio, et al.
The Journal of Urology
|
September 10, 2024
Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma
Mattia Longoni, Giuseppe Rosiello, Alessandro Larcher, et al.
European Urology Oncology
|
June 4, 2019
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery
Umberto Capitanio, Andrea Necchi, Alessandro Larcher, et al.
European Urology
|
December 23, 2015
Reply from Authors re: Matthew C. Hayes, David J. Breen. Excision Versus Ablation in Renal Cancer: Optimising Outcome and Minimising Risk. Eur Urol 2016;69:683-4
Alessandro Larcher, Nicola Fossati, Paolo Dell'Oglio, et al.
Page
of 34